Solana Q4 net income $325.6M ($4.25 EPS) on $5.2M revenue; $293.7M in SOL holdings

Solana Co

Q4 2025 revenue $5.2M (vs $0.2M prior year), driven by $5.1M staking rewards.
Q4 net income $325.6M ($4.25 EPS) vs net loss $3.9M prior year; includes $526.3M derivative gain.
FY 2025 net loss $40.9M ($1.85 loss per share) vs $11.7M loss prior year.
Cash $7.3M, digital assets (SOL) $293.7M at Dec 31, 2025; combined $301M.
Raised $29.9M via ATM in 2025 to buy SOL; repurchased $3.4M stock in 2026 funded by SOL sales.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Solana Co reported financial results for the fiscal quarter and year ended December 31, 2025.

Period: the fiscal quarter and year ended December 31, 2025
Result: reported results

Exact text from the filing

On March 30, 2026, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

Solana Co filing history →

Source: SEC EDGAR

accession 0001104659-26-037118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.